Tamer Elhadidy

Whole-genome sequencing reveals host factors underlying critical COVID-19

Athanasios Kousathanas, Erola Pairo‐Castineira, Konrad Rawlik et al. · Nature · 2022 · 347 citations · Full text

Life Sciences, Infectious Diseases, Molecular Genetics +17

Effect of a combination of nitazoxanide, ribavirin, and ivermectin plus zinc supplement (MANS.NRIZ study) on the clearance of mild COVID‐19

Hatem Elalfy, Tarek Besheer, Ahmed El‐Mesery et al. · Journal of Medical Virology · 2021 · 71 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues

Matteo D’Antonio, Jennifer Nguyen, Timothy D. Arthur et al. · Cell Reports · 2021 · 47 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

RETRACTED ARTICLE: Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study

Mahmoud El‐Bendary, Sherief Abd‐Elsalam, Tamer Elbaz et al. · Expert Review of Anti-infective Therapy · 2021 · 40 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Human Endogenous Retrovirus-H Long Terminal Repeat- Associating Protein 2 (HHLA2) is a Novel Immune Checkpoint Protein in Lung Cancer which Predicts Survival

Mayada Saad Farrag, Eman Ibrahim, Tamer Elhadidy et al. · Asian Pacific Journal of Cancer Prevention · 2021 · 19 citations · Full text

Medicine, Oncology, Pathology +14